Sensome
Founded Year
2014Stage
Series B | AliveTotal Raised
$19.82MLast Raised
$9M | 3 yrs agoAbout Sensome
Sensome develops micro-sensor technology for smart medical devices. Sensome's sensing technology can be integrated with any medical device to reliably identify biological tissues in contact with the device. The technology combines micrometric impedance sensors that communicate wirelessly outside the body and machine learning algorithms for accurate and predictive real-time analysis.
Compete with Sensome?
Ensure that your company and products are accurately represented on our platform.
Sensome's Products & Differentiators
Clotild
a neurovascular guidewire integrating Sensome’s unique sensor technology.
Expert Collections containing Sensome
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Sensome is included in 5 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
10,627 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Medical Devices
9,072 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Digital Health
10,347 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Semiconductors, Chips, and Advanced Electronics
6,343 items
Companies in this collection develop everything from microprocessors to flash memory, integrated circuits specifically for quantum computing and artificial intelligence to OLED for displays, massive production fabs to circuit design firms, and everything in between.
Health IT
7,901 items
Sensome Patents
Sensome has filed 5 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/28/2017 | 3/21/2023 | Stroke, Vascular diseases, Angiology, Hematology, Arteries of the head and neck | Grant |
Application Date | 11/28/2017 |
|---|---|
Grant Date | 3/21/2023 |
Title | |
Related Topics | Stroke, Vascular diseases, Angiology, Hematology, Arteries of the head and neck |
Status | Grant |
Latest Sensome News
Oct 15, 2021
Competitive Strategic Window The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neurovascular Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Neurovascular Devices Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurovascular Devices Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurovascular Devices Market? 4. What is the competitive strategic window for opportunities in the Global Neurovascular Devices Market? 5. What are the technology trends and regulatory frameworks in the Global Neurovascular Devices Market? 6. What is the market share of the leading vendors in the Global Neurovascular Devices Market? 7. What modes and strategic moves are considered suitable for entering the Global Neurovascular Devices Market? Market Dynamics
Sensome Frequently Asked Questions (FAQ)
When was Sensome founded?
Sensome was founded in 2014.
Where is Sensome's headquarters?
Sensome's headquarters is located at Odyssée - Bât. B - 3e étage, Massy.
What is Sensome's latest funding round?
Sensome's latest funding round is Series B.
How much did Sensome raise?
Sensome raised a total of $19.82M.
Who are the investors of Sensome?
Investors of Sensome include Kurma Partners, IDInvest Partners, BNP Paribas, Paris-Saclay University, Asahi Intecc and 4 more.
Who are Sensome's competitors?
Competitors of Sensome include Philips Lifeline and 6 more.
What products does Sensome offer?
Sensome's products include Clotild.
Who are Sensome's customers?
Customers of Sensome include Asahi Intecc.
Compare Sensome to Competitors
Mikroscan develops desktop whole slide scanning solutions. The company's solutions offer ease-of-use, a robust feature set, and exceptional flexibility. With its cost-effective, efficient desktop solutions for pathologists, educators and researchers alike, Mikroscan enables global collaboration when needed.
Qlarity Imaging improves patient care by extracting clinical insights from existing medical images. It builds products that give radiologists information they do not have access to today.
BrightInsight develops a platform for biopharma and medtech-regulated digital health products. The company provides digital health solutions for cardiovascular diseases, diabetes, immunology, oncology, and more. It was formerly known as Flex Digital Health. The company was founded in 2017 and is based in San Jose, California.
heartbeat medical is a software company that aims to revolutionize the way doctors and hospitals evaluate the success of their treatments. heartbeat's software empowers doctors to practice personalized, data-driven medicine that puts a patient's needs first. The software seamlessly integrates the collections of Patient Reported Outcomes (PROs) into a clinical setting. Following a treatment, heartbeat automatically follows up with a patient at regular intervals and asks them how they are doing. The data that is collected conforms with recognized international reporting standards. This makes it easy for doctors to compare their patients' outcomes with thousands of established data sets. In this way, patients' quality of life can become the new benchmark in healthcare. heartbeat medical was founded in 2014 and is based in Berlin, Germany.
Netsensing Technology develops sleep apnea detection medical devices.
technology for real-time monitoring of the metabolic state of the patient and as a endpoint of resuscitationn nCritisense's first generation product - the "CritiView" is an patient monitoring system providing real-time continuous information via four physiological parameters, sensed at the tissue level, reflecting the systemic metabolic state. nCritiView is the only device providing continuous, real-time multi-parametric physiological data at the tissue and cellular level, by monitoring the mitochondrial function and the microcirculatory blood flow and oxygen saturation.n
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.